title: Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
authors.forename: H
authors.initials: H
authors.lastname: Yasuda
authors.forename: A
authors.initials: A
authors.lastname: Hirai
authors.forename: M
authors.initials: M
authors.lastname: Joko
authors.forename: M
authors.initials: M
authors.lastname: Terada
authors.forename: T
authors.initials: T
authors.lastname: Kawabata
authors.forename: K
authors.initials: K
authors.lastname: Maeda
authors.forename: M
authors.initials: M
authors.lastname: Haneda
authors.forename: A
authors.initials: A
authors.lastname: Kashiwagi
authors.forename: T
authors.initials: T
authors.lastname: Maeda
authors.forename: R
authors.initials: R
authors.lastname: Kikkawa
mesh_terms: D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000473:pathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009412:Nerve Fibers / Q000187:drug effects / Q000473:pathology*; D012236:Rhodanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012867:Skin / Q000294:innervation; D053778:Thiazolidines
chemical_list: D004791:Enzyme Inhibitors; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D000449:Aldehyde Reductase